Share General Information
Montelukast sodium is an orally active compound that belongs to a class of molecules termed leukotriene receptor antagonists (LTRAs) and is approved for the treatment of symptoms related to asthma and allergic rhinitis (hay fever). It is also prescribed to prevent exercise-induced bronchospasm. Montelukast sodium inhibits the binding of leukotrienes (molecules secreted by white blood cells) to a receptor that triggers an inflammatory response. Due to its mechanism of action, this drug is not prescribed for the treatment of acute asthma attacks.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
